Eli Lilly Aktie

632,30 EUR -0,90 EUR -0,14 %

13:35:15

STU

714,13 USD -10,46 USD -1,44 %

vorbörslich13:48:05

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.597,94 Mrd. EUR

KGV65,91Div. Rendite0,67%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

Sortieren:Datum Meistgelesen

30.10.24Financial TimesShares in weight-loss drugmaker Eli Lilly fall on disappointing sales

30.10.24finanzen.netAusblick

Ausblick: Eli Lilly vermeldet Zahlen zum jüngsten Quartal

30.10.24EN, Eli LillyLilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products

30.10.24PR NewswireLilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products

30.10.24BenzingaZepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

30.10.24MotleyFoolIs Eli Lilly Stock a Buy?

30.10.24finanzen.netDAX schließt klar im Minus -- Wall Street schwach -- VW verzeichnet drastischen Gewinnrückgang -- BASF vorsichtiger für 2024 -- Gewinnplus von AMD enttäuscht -- US-Wahl, Alphabet, Trump Media im Fokus

29.10.24ZacksCan Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?

29.10.24BenzingaEli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's

29.10.24BenzingaEli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains (CORRECTED)

29.10.24EN, Eli LillyModified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study

29.10.24PR NewswireModified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study

29.10.24finanzen.netPerformance im Blick

S&P 500-Titel Eli Lilly-Aktie: So viel hätte eine Investition in Eli Lilly von vor 5 Jahren abgeworfen

29.10.24MotleyFool1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever

28.10.24PR NewswireLilly declares fourth-quarter 2024 dividend

28.10.24EN, Eli LillyLilly declares fourth-quarter 2024 dividend

28.10.24EN, Eli LillyLilly's mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn's disease

28.10.24PR NewswireLilly's mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn's disease

28.10.24Business TimesEli Lilly gets nod to launch blockbuster weight-loss drug in Hong Kong

27.10.24MotleyFoolBillionaire Stanley Druckenmiller Closed Out His Position in Eli Lilly Stock. 3 Reasons Why I'm Still a Buyer.

25.10.24ZacksInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

25.10.24PR NewswireLilly's EBGLYSS™ (lebrikizumab-lbkz) demonstrated meaningful improvement in skin clearance and itch relief in the majority of patients with moderate-to-severe atopic dermatitis who discontinued du...

23.10.24BenzingaEli Lilly Alzheimer's Drug Faces Tough Road In UK, Price Watchdog NICE Says Donanemab Is Not Cost-Effective

23.10.24ZacksEli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

23.10.24PR NewswireLilly's Kisunla™ (donanemab-azbt) Receives Marketing Authorization in Great Britain for the Treatment of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in Adult Patients Wh...

22.10.24finanzen.netEli Lilly-Investment

S&P 500-Titel Eli Lilly-Aktie: So viel hätten Anleger an einem Eli Lilly-Investment von vor 3 Jahren verdient

21.10.24BenzingaEli Lilly Sues Some Vendors For Unauthorized Sale Of Fake Weight-Loss Drug

20.10.24MotleyFool1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now

17.10.24Benzinga$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today

17.10.24MotleyFoolThis is Huge News For Eli Lilly Investors

17.10.24ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

16.10.24MotleyFool3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon

16.10.24EN, Eli LillyLilly confirms date and conference call for third-quarter 2024 financial results announcement

16.10.24PR NewswireLilly confirms date and conference call for third-quarter 2024 financial results announcement

16.10.24MotleyFoolThis Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024

16.10.24PR NewswireSurvey reveals 8 in 10 Americans with ulcerative colitis struggle to find a public restroom during emergencies

16.10.24MotleyFoolEli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

16.10.24MotleyFoolShould Eli Lilly Investors Worry About This Unexpected FDA Move?

15.10.24BenzingaEli Lilly Unusual Options Activity

15.10.24finanzen.netPerformance im Blick

S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte ein Investment in Eli Lilly von vor einem Jahr abgeworfen

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.